{
    "2020-07-16": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Alcami Corporation -- Moody's downgrades Alcami's CFR to Caa2; outlook negative",
                "features": {
                    "keywords": [
                        "downgrades",
                        "CFR",
                        "Caa2",
                        "outlook negative"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "3 Inexpensive MedTech Gainers of 2H20 Beyond TMO and RMD",
                "features": {
                    "keywords": [
                        "Inexpensive",
                        "MedTech",
                        "Gainers",
                        "TMO",
                        "RMD"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "medical technology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Thermo Fisher raises bid for Qiagen to 43 eur/shr",
                "features": {
                    "keywords": [
                        "Thermo Fisher",
                        "raises bid",
                        "Qiagen",
                        "43 eur/shr"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement",
                "features": {
                    "keywords": [
                        "Thermo Fisher Scientific",
                        "QIAGEN N.V.",
                        "Agree",
                        "Amended Terms",
                        "Acquisition Agreement"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}